GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (FRA:HO1) » Definitions » Current Deferred Revenue

Hologic (FRA:HO1) Current Deferred Revenue : €191 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hologic Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Hologic's current deferred revenue for the quarter that ended in Mar. 2024 was €191 Mil.

Hologic Current Deferred Revenue Historical Data

The historical data trend for Hologic's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Current Deferred Revenue Chart

Hologic Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 162.99 158.00 168.30 188.37 186.65

Hologic Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.29 214.97 186.65 174.78 191.36

Hologic Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Hologic's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hologic (FRA:HO1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (FRA:HO1) » Definitions » Current Deferred Revenue
Comparable Companies
COO BAX TFX ATR WST RGEN STVN XRAY HAE MMSI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B TSE:4543 XSWX:STMN XPAR:DIM
Traded in Other Exchanges
HOLX:USA HOLX:Mexico HOLX:Austria
Address
250 Campus Drive, Marlborough, MA, USA, 01752
Website
http://www.hologic.com
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (FRA:HO1) Headlines

No Headlines